Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia

The development of secondary non-response (SNR) to botulinum neurotoxin type-A (BoNT-A) is considered a key issue in the management of cervical dystonia (CD). This case-controlled study was performed to systematically identify factors influencing SNR during BoNT-A therapy.

Source: Parkinsonism and Related Disorders - November 19, 2014 Category: Neurology Authors: Joaquim J. Ferreira, Carlo Colosimo, Roongroj Bhidayasiri, Maria Jose Marti, Pascal Maisonobe, Om Savary Source Type: research